Institution
Azienda Ospedaliero-Universitaria di Modena
Recent research
- Health & MedicineOpen access
ABSTRACT Background Although the association between erectile dysfunction (ED) and cardiovascular disease is well established, its prevalence in patients with atherosclerosis remains poorly defined. Objectives To evaluate ED prevalence, severity, and associated risk factors (RFs)...
- Health & MedicineOpen access
Isavuconazole is a broad-spectrum antifungal agent approved for the treatment of invasive fungal infections (IFIs) in adults and, recently, in pediatric patients aged 1 year and older. Use in the pediatric setting remains limited, but available data indicate generally favorable s...
- Health & MedicineOpen access
Background and Aim: The identification of factors that optimize competitive performance is a primary focus for athletes and coaches in any sport, particularly variables that are modifiable through tailored nutritional and training strategies. Since data regarding volleyball remai...
- Health & MedicineOpen access
Persistent infection with high-risk human papillomavirus (HR-HPV) is a common clinical condition for which no validated systemic antiviral therapy is currently available, and in the absence of high-grade cervical lesions management is generally limited to surveillance. Active Hex...
- Health & MedicineOpen access
ABSTRACT Dementia is a syndrome that affects millions of people in the world, and Alzheimer's disease (AD) is the most common cause. The diagnosis of AD begins with cognitive symptoms such as mild cognitive impairment (MCI) but requires the demonstration and quantification of the...
- Health & MedicineOpen access
Impact of Menopause and Menopausal Hormone Therapy on Liver–Kidney–Metabolic Health
Menopause is associated with unfavorable metabolic changes that may contribute to the development of metabolic dysfunction-associated steatotic liver disease (MASLD), chronic kidney disease (CKD), and increased cardiometabolic risk. Within the evolving cardiovascular-kidney-metab...
- Health & Medicine
Summary Venetoclax (VEN) plus hypomethylating agents (HMAs) represents the standard of care for newly diagnosed acute myeloid leukaemia (AML) patients unfit for intensive chemotherapy, but prospective real‐world observational data outside randomized clinical trials remain limited...
- Health & MedicineOpen access
Background: European approval of lecanemab and donanemab has shifted anti-amyloid monoclonal antibodies from trial evidence to health-system implementation. In Italy, reimbursement decisions are pending, and real-world estimates of treatment-ready eligibility under Italian approp...
- Health & MedicineOpen access
Objectives: This systematic review evaluated externally validated, clinician-comparative studies of artificial intelligence (AI)-based fracture detection on conventional radiography and computed tomography (CT) and summarized diagnostic performance by imaging modality. Material a...